STAGE I & II MANTLE-CELL LYMPHOMA: CLINICAL OUTCOMES WITH COMBINED MODALITY THERAPY

被引：0
|
作者：
Bernard, M. [1 ]
Tsang, R. W. [2 ]
Le, L. W. [2 ]
Hodgson, D. C. [2 ]
Sun, A. [2 ]
Wells, W. [2 ]
Crump, M. [2 ]
Gospodarowicz, M. K. [2 ]
机构：
[1] Hop Maison Neuve Rosemont, Montreal, PQ, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [21] Mantle-cell lymphoma: A population-based clinical study
    Velders, GA
    KluinNelemans, JC
    DeBoer, CJ
    Hermans, J
    Noordijk, EM
    Schuuring, E
    Kramer, MHH
    VanDeijk, WA
    Rahder, JB
    Kluin, PM
    VanKrieken, JHJM
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1269 - 1274
  • [22] Haematological polyposis: Mantle-cell lymphoma
    Canamares Orbis, Pablo
    Alfaro Almajano, Enrique
    de la Torreb, Viviana Laredo
    Hijos Mallada, Gonzalo
    Abad Baroja, Daniel
    Velamazan Sandalinas, Raul
    Garcia Mateo, Sandra
    Hernandez Ainsa, Maria
    Saura Blasco, Nuria
    Martinez Dominguez, Samuel Jesus
    Borao Lagunaba, Cristina
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 : 50 - 52
  • [23] CNS involvement in Mantle-cell lymphoma
    Montserrat, E
    Bosch, F
    LopezGuillermo, A
    Graus, F
    Terol, MJ
    Campo, E
    Rozman, C
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 941 - 944
  • [24] Treatment of Mantle-Cell Lymphoma REPLY
    Wang, Michael L.
    Le Gouill, Steven
    Dreyling, Martin
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (12): : 1148 - 1148
  • [25] Maintenance rituximab in mantle-cell lymphoma
    Burki, Talha Khan
    LANCET ONCOLOGY, 2017, 18 (11): : E647 - E647
  • [26] Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network
    Hoster, Eva
    Klapper, Wolfram
    Hermine, Olivier
    Kluin-Nelemans, Hanneke C.
    Walewski, Jan
    van Hoof, Achiel
    Trneny, Marek
    Geisler, Christian H.
    Di Raimondo, Francesco
    Szymczyk, Michal
    Stilgenbauer, Stephan
    Thieblemont, Catherine
    Hallek, Michael
    Forstpointner, Roswitha
    Pott, Christiane
    Ribrag, Vincent
    Doorduijn, Jeanette
    Hiddemann, Wolfgang
    Dreyling, Martin H.
    Unterhalt, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (13) : 1338 - 1346
  • [27] STAGE-I AND STAGE-II DIFFUSE LARGE CELL LYMPHOMA (DLCL) TREATED WITH COMBINED MODALITY PROGRAM
    VELASQUEZ, WS
    JAGANNATH, S
    FULLER, LM
    TUCKER, S
    HAGEMEISTER, FB
    MCLAUGHLIN, P
    CABANILLAS, F
    CANCER DRUG DELIVERY, 1986, 3 (01): : 90 - 90
  • [28] Composite mantle-cell lymphoma and plasmacytoma
    Cachia, AR
    Diss, TC
    Isaacson, PG
    HUMAN PATHOLOGY, 1997, 28 (11) : 1291 - 1295
  • [29] Composite mantle-cell lymphoma and classical Hodgkin lymphoma
    Hayes, SJ
    Banerjee, SS
    Cook, Y
    Houghton, JB
    Menasce, LP
    HISTOPATHOLOGY, 2006, 48 (05) : 621 - 623
  • [30] CAR T-cell therapy for relapsed or refractory mantle-cell lymphoma
    Stirrups, Robert
    LANCET ONCOLOGY, 2020, 21 (05): : E239 - E239
12345